Cat. # | Size | Qty. | Price |
---|---|---|---|
41855S | 1 Kit (96 assays) |
|
Product Includes | Quantity (with Count) | Storage Temp | |||
---|---|---|---|---|---|
PMA (1 mM) Assay Reagent | 1 x 50 µl | -20°C | |||
S7 Nuclease Assay Reagent | 1 x 50 µl | -20°C | |||
NET Assay Neutrophil Elastase Substrate | 2 x 250 µl | -20°C | |||
Human Neutrophil Elastase Assay Reagent | 1 x 50 µl | -20°C | |||
Bovine Serum Albumin Assay Reagent | 1 x 5 g | +4°C | |||
EDTA (500 mM) Assay Reagent | 1 x 1 ml | RT | |||
Calcium Chloride (1 M) Assay Reagent | 1 x 1 ml | RT | |||
96-Well Solid Plate (Colorimetric Assay) | 1 x 96 tests | RT | |||
96-Well Cover Sheet | 1 x 1 ea | RT |
Product Information
Supplied Reagents
To prepare the NET assay buffer, combine 500 mL of RPMI 1640 base medium (not provided) with 5 g of Bovine Serum Albumin Assay Reagent #50855 and 500 µL of Calcium Chloride (1 M) Assay Reagent #60648. The NET assay buffer is not intended to be sterile and does not need to be prepared or used in a tissue culture hood. Pre-warm the NET assay buffer to 37°C prior to cell stimulation and addition of nuclease to ensure rapid activation and subsequent nuclease activity. For storage of unused NET assay buffer, sterile filter, aliquot, and store at -20°C.
NOTE: Serum contains DNAse that will digest NETs and should be avoided if possible.
To run a standard curve using the Human Neutrophil Elastase Assay Reagent #42211, obtain eight clean test tubes and label them #1 through #8. NOTE: While the NET assay buffer will serve as an adequate diluent for the Human Neutrophil Elastase Assay Reagent, we recommend adding 400 µL of EDTA (500 mM) Assay Reagent (#79598) to 20 mL of NET assay buffer and using this for the dilutions of the Human Neutrophil Elastase Assay Reagent. Add 5 mL of pre-warmed NET assay buffer into tube #1 and 1 mL into tubes #2-8. Transfer 10 µL of Human Neutrophil Elastase Assay Reagent into tube #1 and mix thoroughly. The concentration of this standard is 36 mU/mL. Serially dilute the standard by removing 1 mL from tube #1 and placing it into tube #2; mix thoroughly. Next remove 1 mL from tube #2 and place it into tube #3; mix thoroughly. Repeat for tubes #4-7. Do not add any standard to tube #8. This tube will be your blank.
Reagent Preparation for treating cells in a 96-well plate (not provided)
Reagent Preparation for treating cells in a 24-well plate (not provided)
Additional Reagents (Not Supplied)
The following protocol is designed for a 96-well or 24-well tissue culture plate (not provided).
There is no specific pattern for using the wells on the plate. Each standard and sample should be assayed at least in duplicate.
Use the clear 96-Well Solid Plate (Colorimetric Assay) #75820 included in the kit to perform the assay described below. For optimal results, we recommend pre-warming the standards and samples to 37°C in a water bath prior to performing the NETosis assay.
Plotting the Standard Curve and Determining the Sample Elastase Activity:
Plot absorbance (linear y-axis) versus concentration (linear x-axis) for standards (S1-S8) and fit the data with a quadratic equation. Using the equation of the line, calculate the elastase activity in each sample. Alternatively, a plot of concentration (y-axis) and absorbance (x-axis) can be performed. This plot has the benefit of easier calculation of elastase activity based on the best-fit quadratic equation.
Protocol Id: 3064
NETosis is a unique form of regulated cell death that is characterized by membrane rupture and the extrusion of chromatin, histones, and granular and cytoplasmic components into a web-like structure called neutrophil extracellular traps (NETs) (reviewed in 1). NETosis has been associated with host defense to pathogens as well as a number of disease states, including autoimmune diseases, thrombosis, cardiovascular diseases, and tumor progression. NETosis was identified as a response to bacterial infection and can be activated by lipopolysaccharide (LPS) as well as inflammatory pathway activators like phorbol-12-myristate-13-acetate (PMA) (2). It can occur via multiple pathways, but several key players have emerged. The calcium-dependent enzyme protein-arginine deiminase 4 (PAD4) catalyzes hypercitrullination of histones that contributes to chromatin decondensation (3,4). In addition, activation of proteases, including neutrophil elastase (ELANE), myeloperoxidase (MPO), and Cathepsin G, leads to impairment of cytoskeletal structures and degradation of histones during NETosis (5,6).
Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.
Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.